Cited by 17,038Global Cancer Incidence and ScreeningColorectal Cancer Screening and DetectionEconomic and Financial Impacts of Cancer

The DOI matches its Crossref record; 83 of the 85 references it cites were found in a registry or an index.

Cancer statistics in China, 2015

Open access

Chen, Wanqing, Zheng, Rongshou, Baade, Peter D., Zhang, Siwei, Zeng, Hongmei, Bray, Freddie, Jemal, Ahmedin, Yu, Xue Qin, He, Jie·2016·CA: A Cancer Journal for Clinicians

DOI 10.3322/caac.21338

Open this paper in CoChat — free account Open PDF

Abstract

With increasing incidence and mortality, cancer is the leading cause of death in China and is a major public health problem. Because of China's massive population (1.37 billion), previous national incidence and mortality estimates have been limited to small samples of the population using data from the 1990s or based on a specific year. With high‐quality data from an additional number of population‐based registries now available through the National Central Cancer Registry of China, the authors analyzed data from 72 local, population‐based cancer registries (2009‐2011), representing 6.5% of the population, to estimate the number of new cases and cancer deaths for 2015. Data from 22 registries were used for trend analyses (2000‐2011). The results indicated that an estimated 4292,000 new cancer cases and 2814,000 cancer deaths would occur in China in 2015, with lung cancer being the most common incident cancer and the leading cause of cancer death. Stomach, esophageal, and liver cancers were also commonly diagnosed and were identified as leading causes of cancer death. Residents of rural areas had significantly higher age‐standardized (Segi population) incidence and mortality rates for all cancers combined than urban residents (213.6 per 100,000 vs 191.5 per 100,000 for incidence; 149.0 per 100,000 vs 109.5 per 100,000 for mortality, respectively). For all cancers combined, the incidence rates were stable during 2000 through 2011 for males (+0.2% per year; P = .1), whereas they increased significantly (+2.2% per year; P < .05) among females. In contrast, the mortality rates since 2006 have decreased significantly for both males (−1.4% per year; P < .05) and females (−1.1% per year; P < .05). Many of the estimated cancer cases and deaths can be prevented through reducing the prevalence of risk factors, while increasing the effectiveness of clinical care delivery, particularly for those living in rural areas and in disadvantaged populations. CA Cancer J Clin 2016;66:115–132. © 2016 American Cancer Society.

Integrity signals

Registry

Crossref · 10.3322/caac.21338

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Global cancer statistics
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,044
Self-citation
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,858
Self-citation
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,468
Self-citation
China statistical yearbook
中華人民共和国国家統計局 (1988) · Medical Entomology and Zoology · Cited by 12,443
Cancer statistics, 2015
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,854
Self-citation
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,404
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Cancer Incidence in Five Continents
Doll, R., Muir, C. S., & Waterhouse, J. A. H. (1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,485
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
The Health consequences of smoking—50 years of progress : a report of the Surgeon General
Lushniak, B. D., Samet, J. M., Pechacek, T. F., Norman, L., & Taylor, P. A. (2014) · Cited by 4,990

Flagged first, then by citations

Show all 85 references

2 of the 85 references couldn’t be matched to a known paper.

Research works printed but not linked: 5

National Cancer Center, Disease Prevention and Control Bureau, Ministry of Health, 2012, Chinese Cancer Registry Annual Report 2012
Ferlay J, 2005, Check and Conversion Programs for Cancer Registries (IARC/IACR Tools for Cancer Registries). IARC Technical Report No. 42
Chen Z, 2008, National Death Survey Report 2004–2005
2015, Will China make the great leap in tobacco control in 2015 [editorial]?, Lancet., 385, 2122
Kang LN, 2014, Cancer screening and prevention in China [serial online], Cancer Control 2014., 131

Sorted by citations

Items 501–600 of 1,032

Hsa_circ_0005986 inhibits carcinogenesis by acting as a miR-129-5p sponge and is used as a novel biomarker for hepatocellular carcinoma
Fu, L., Chen, Q., Yao, T. S., Li, T., Ying, S., Hu, Y., & Guo, J. (2017) · Oncotarget · doi:10.18632/oncotarget.16709 · Cited by 118
Systemic immune-inflammation index predicts prognosis of patients with advanced pancreatic cancer
Zhang, K., Hua, Y., Wang, D., Chen, L., Wu, C., Chen, Z., Liu, L., & Chen, H. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1782-x · Cited by 121
The lncRNA BDNF-AS/WDR5/FBXW7 axis mediates ferroptosis in gastric cancer peritoneal metastasis by regulating VDAC3 ubiquitination
Huang, G., Xiang, Z., Wu, H., He, Q., Dou, R., Lin, Z., Yang, C., Huang, S., Song, J., Di, Z., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.69454 · Cited by 118
A graphene quantum dots based electrochemiluminescence immunosensor for carcinoembryonic antigen detection using poly(5-formylindole)/reduced graphene oxide nanocomposite
Nie, G., Wang, Y., Tang, Y., Zhao, D., & Guo, Q. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.10.021 · Cited by 116
A comprehensive genome‐wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma
Cui, H., Zhang, Y., Zhang, Q., Chen, W., Zhao, H., & Liang, J. (2017) · Cancer Medicine · doi:10.1002/cam4.1180 · Cited by 116
Self-citation
Transfer of LncRNA CRNDE in TAM-derived exosomes is linked with cisplatin resistance in gastric cancer
Lin, X., Zhou, L., Liu, C., Zeng, F., Yuan, Y., Zhou, Q., Li, S., Wu, Y., Wang, J., Wu, D., et al. (2021) · EMBO Reports · doi:10.15252/embr.202052124 · Cited by 120
“In China, GC is the second leading cause of cancer death after lung cancer (Chen et al , 2016; Huang et al , 2020).”
Cell membrane-coated nanomaterials for cancer therapy
Zeng, S., Tang, Q., Xiao, M., Tong, X., Yang, T., Yin, D., Lei, L., & Li, S. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100633 · Cited by 118
Immune signature profiling identified predictive and prognostic factors for esophageal squamous cell carcinoma
Li, Y., Lu, Z., Che, Y., Wang, J., Sun, S., Huang, J., Mao, S., Lei, Y., Chen, Z., & He, J. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1356147 · Cited by 115
Self-citation
UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53
Liu, L., Yang, M., Peng, Q., Li, M., Zhang, Y., Guo, Y., Chen, Y., & Bao, S. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.09.091 · Cited by 116
Mortality of lymphoma and myeloma in China, 2004–2017: an observational study
Liu, W., Liu, J., Song, Y., Wang, X., Zhou, M., Wang, L., Ma, J., & Zhu, J. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0706-9 · Cited by 115
Classification of white blood cells using weighted optimized deformable convolutional neural networks
Yao, X., Sun, K., Bu, X., Zhao, C., & Yu, J. (2021) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2021.1879823 · Cited by 115
CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K/AKT pathway
Wang, L., Zhou, Y., Jiang, L., Lu, L., Dai, T., Li, A., Chen, Y., & Zhang, L. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01332-8 · Cited by 115
Landscape of somatic alterations in large-scale solid tumors from an Asian population
Wu, L., Yao, H., Chen, H., Wang, A., Guo, K., Gou, W., Yu, Y., Li, X., Yao, M., Yuan, S. H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31780-9 · Cited by 122
Self-citation
Exosomal miR-93 promotes proliferation and invasion in hepatocellular carcinoma by directly inhibiting TIMP2/TP53INP1/CDKN1A
Xue, X., Wang, X., Zhao, Y., Hu, R., & Qin, L. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.208 · Cited by 116
Application of Traditional Chinese Medicines as Personalized Therapy in Human Cancers
Wang, S., Long, S., & Wu, W. (2018) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x18500507 · Cited by 114
Circ-SFMBT2 promotes the proliferation of gastric cancer cells through sponging miR-182-5p to enhance CREB1 expression
Sun, H., Xi, P., Sun, Z., Wang, Q., Zhu, B., Zhou, J. P., Jin, H. Z., Zheng, W., Tang, W., Cao, H., et al. (2018) · Cancer Management and Research · doi:10.2147/cmar.s172592 · Cited by 113
Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer
Li, Y., Zheng, D., Wang, F., Xu, Y., Yu, H., & Zhang, H. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5452-2 · Cited by 114
Light/pH-Triggered Biomimetic Red Blood Cell Membranes Camouflaged Small Molecular Drug Assemblies for Imaging-Guided Combinational Chemo-Photothermal Therapy
Ye, S., Wang, F., Fan, Z., Zhu, Q., Tian, H., Zhang, Y., Jiang, B., Hou, Z., Li, Y., & Su, G. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b00897 · Cited by 113
Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing
Cai, H., Jing, C., Chang, X., Ding, D., Han, T., Yang, J., Lu, Z., Hu, X., Liu, Z., Wang, J., et al. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1941-0 · Cited by 115
N6-methyladenosine (m6A) RNA modification in gastrointestinal tract cancers: roles, mechanisms, and applications
Hu, B., Wang, X.-Y., Gu, X., Zou, C., Gao, Z., Zhang, H., & Fan, Y. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1099-7 · Cited by 115
The novel GINS4 axis promotes gastric cancer growth and progression by activating Rac1 and CDC42
Zhu, Z., Yu, Z., Rong, Z., Luo, Z., Zhang, J., Qiu, Z., & Huang, C. (2019) · Theranostics · doi:10.7150/thno.36256 · Cited by 114
Calcium and TRPV4 promote metastasis by regulating cytoskeleton through the RhoA/ROCK1 pathway in endometrial cancer
Li, X., Cheng, Y., Wang, Z., Zhou, J., Jia, Y., He, X., Zhao, L., Dong, Y., Fan, Y., Yang, X., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03181-7 · Cited by 114
Nutritional assessment and risk factors associated to malnutrition in patients with esophageal cancer
Cao, J., Xu, H., Li, W., Guo, Z., Lin, Y., Shi, Y., Hu, W., Ba, Y., Li, S., Li, Z., et al. (2020) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2020.100638 · Cited by 114
Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway
Zang, M., Hu, L., Fan, Z., Wang, H., Zhu, Z., Cao, S., Wu, X., Li, J., Su, L., Li, C., et al. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1151-6 · Cited by 113
Morusin induces paraptosis-like cell death through mitochondrial calcium overload and dysfunction in epithelial ovarian cancer
Xue, J., Li, R., Zhao, X., Ma, C., Lv, X., Liu, L., & Liu, P. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.02.003 · Cited by 114
Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice
Peng, K., Kou, L., Li, Y., Bai, C., Li, M., Mo, P., Li, W., & Yu, C. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.11.036 · Cited by 112
Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis
Shen, S. Y., Kong, J., Qiu, Y., Yang, X., Wang, W., & Yan, L. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28290 · Cited by 111
Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer
Zhao, H., Huang, T., & Li, H. (2019) · Surgery · doi:10.1016/j.surg.2019.01.025 · Cited by 113
The m6A-suppressed P2RX6 activation promotes renal cancer cells migration and invasion through ATP-induced Ca2+ influx modulating ERK1/2 phosphorylation and MMP9 signaling pathway
Gong, D., Zhang, J., Chen, Y., Xu, Y., Ma, J., Hu, G., Yi-ran, H., Zheng, J., Zhai, W., & Xue, W. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1223-y · Cited by 113
Aptamer-Functionalized and Gold Nanoparticle Array-Decorated Magnetic Graphene Nanosheets Enable Multiplexed and Sensitive Electrochemical Detection of Rare Circulating Tumor Cells in Whole Blood
Dou, B., Xu, L., Jiang, B., Yuan, R., & Xiang, Y. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b02403 · Cited by 114
Effective and persistent antitumor activity of HER2-directed CAR-T cells against gastric cancer cells in vitro and xenotransplanted tumors in vivo
Song, Y., Tong, C., Wang, Y., Gao, Y., Dai, H., Guo, Y., Zhao, X., Wang, Y., Wang, Z., Han, W., et al. (2017) · Protein & Cell · doi:10.1007/s13238-017-0384-8 · Cited by 112
Identification of core genes and outcome in gastric cancer using bioinformatics analysis
Sun, C., Yuan, Q., Wu, D., Meng, X., & Wang, B. (2017) · Oncotarget · doi:10.18632/oncotarget.20082 · Cited by 112
Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression
Guo, J., Wu, Y., Du, J., Yang, L., Chen, W., Gong, K., Dai, J., Miao, S., Jin, D., & Xi, S. (2018) · Oncogenesis · doi:10.1038/s41389-018-0054-6 · Cited by 115
Self-citation
Dihydroartemisinin Inhibits the Proliferation, Colony Formation and Induces Ferroptosis of Lung Cancer Cells by Inhibiting PRIM2/SLC7A11 Axis
Yuan, B., Liao, F., Shi, Z., Ren, Y., Deng, X., Yang, T.-T., Li, D.-Y., Li, R.-F., Pu, D., Wang, Y., et al. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s248492 · Cited by 112
Tumor-Associated Macrophages Promote Oxaliplatin Resistance via METTL3-Mediated m 6 A of TRAF5 and Necroptosis in Colorectal Cancer
Lan, H., Liu, Y., Liu, J., Wang, X., Guan, Z., Du, J., & Jin, K. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00961 · Cited by 112
A mutational signature associated with alcohol consumption and prognostically significantly mutated driver genes in esophageal squamous cell carcinoma
Li, X., Wang, M., Yang, M., Dai, H., Zhang, B., Wang, W., Chu, X. L., Wang, X., Zheng, H., Niu, R., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy011 · Cited by 111
Circulating lncRNA XLOC_009167 serves as a diagnostic biomarker to predict lung cancer
Jiang, N., Meng, X., Mi, H., Chi, Y., Li, S., Jin, Z., Tian, H., He, J., Shen, W., Tian, H., et al. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.07.026 · Cited by 111
Self-citation
Multiple Primary Malignant Tumors - A Clinical Analysis of 15,321 Patients with Malignancies at a Single Center in China
Zhai, C., Cai, Y., Lou, F., Liu, Z., Xie, J., Zhou, X., Wang, Z., Fang, Y., Pan, H., & Han, W. (2018) · Journal of Cancer · doi:10.7150/jca.25482 · Cited by 111
The Carcinogenic Role of the Notch Signaling Pathway in the Development of Hepatocellular Carcinoma
Huang, Q., Li, J., Zheng, J., & Wei, A. (2019) · Journal of Cancer · doi:10.7150/jca.26847 · Cited by 111
PRDX2 protects against oxidative stress induced by H. pylori and promotes resistance to cisplatin in gastric cancer
Wang, S., Chen, Z., Zhu, S., Lu, H., Peng, D., Soutto, M., Naz, H., Peek, R. M., Xu, H., Zaika, A. I., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101319 · Cited by 111
Characterization and anti-tumor activity of exopolysaccharide produced by Lactobacillus kefiri isolated from Chinese kefir grains
Rajoka, M. S. R., Mehwish, H. M., Fang, H., Padhiar, A. A., Zeng, X., Khurshid, M., He, Z., & Zhao, L. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103588 · Cited by 113
Sex difference in incidence of gastric cancer: an international comparative study based on the Global Burden of Disease Study 2017
Lou, L., Wang, L., Zhang, Y., Chen, G., Lin, L., Jin, X., Huang, Y., & Chen, J. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-033323 · Cited by 116
Exosomal transfer of miR-15b-3p enhances tumorigenesis and malignant transformation through the DYNLT1/Caspase-3/Caspase-9 signaling pathway in gastric cancer
Wei, S., Peng, L., Yang, J., Sang, H., Jin, D., Li, X., Chen, M., Zhang, W., Dang, Y., & Zhang, G. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1511-6 · Cited by 112
EGFR exon 20 insertion mutations in Chinese advanced non-small cell lung cancer patients: Molecular heterogeneity and treatment outcome from nationwide real-world study
Yang, G., Li, J., Xu, H., Yang, Y., Yang, L., Xu, F., Xia, B., Zhu, V. W., Nagasaka, M., Yang, Y., et al. (2020) · Lung Cancer · doi:10.1016/j.lungcan.2020.03.014 · Cited by 114
Addition of camrelizumab to docetaxel, cisplatin, and radiation therapy in patients with locally advanced esophageal squamous cell carcinoma: a phase 1b study
Zhang, W., Yan, C., Zhang, T., Chen, X., Dong, J., Zhao, J., Han, D., Wang, J., Zhao, G., Cao, F., et al. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1971418 · Cited by 111
Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC)
Tang, Z., Shen, Q., Xie, H., Zhou, X., Li, J., Feng, J., Liu, H., Wang, W., Zhang, S., & Ni, S. (2016) · Oncotarget · doi:10.18632/oncotarget.10086 · Cited by 110
Self-citation
Detecting Circulating Tumor DNA in Hepatocellular Carcinoma Patients Using Droplet Digital PCR Is Feasible and Reflects Intratumoral Heterogeneity
Huang, A., Zhang, X., Zhou, S., Cao, Y., Huang, X., Fan, J., Yang, X., & Zhou, J. (2016) · Journal of Cancer · doi:10.7150/jca.15823 · Cited by 113
Primary Antibiotic Resistance of Helicobacter pylori in China
Hu, Y., Zhu, Y., & Lü, N. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4536-8 · Cited by 110
MAPK Pathway and TERT Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 Cases
Bai, X. L., Kong, Y., Chi, Z., Sheng, X., Cui, C., Wang, X., Mao, L., Tang, B., Li, S., Lian, B., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0980 · Cited by 114
SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma
Yang, Y.-F., Zhang, M., Tian, Q., Fu, J., Yang, X., Zhang, C. Z., & Yang, H. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0872-3 · Cited by 110
Quercetin and doxorubicin co-delivery using mesoporous silica nanoparticles enhance the efficacy of gastric carcinoma chemotherapy
Fang, J., Zhang, S., Xue, X., Zhu, X., Song, S., Wang, B., Jiang, L., Qin, M., Liang, H., & Gao, L. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s170862 · Cited by 110
Self-citation
Efficacy and safety of immune checkpoint inhibitors in advanced gastric or gastroesophageal junction cancer: a systematic review and meta-analysis
Chen, C., Zhang, F., Zhou, N., Gu, Y., Zhang, Y., He, Y.-D., Wang, L., Yang, L., Zhao, Y., & Li, Y. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1581547 · Cited by 110
Long noncoding RNA SNHG14 facilitates colorectal cancer metastasis through targeting EZH2-regulated EPHA7
Wu, D., Weinan, X., Li, X., Yu, Z.-W., Gu, X.-Y., Jinxue, T., & Li, M. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1707-x · Cited by 110
Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer
Tao, Y., Tang, Y., Yang, Z., Wu, F., Wang, L., Yang, L., Li, L., Jing, Y., Jiang, X., Jin, H., et al. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.39123 · Cited by 108
Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy
Li, Z., Gao, X., Peng, X., Chen, M.-J. M., Li, Z., Wei, B., Wen, X., Wei, B., Dong, Y., Bu, Z., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay4211 · Cited by 112
Imaging γ-Glutamyltranspeptidase for tumor identification and resection guidance via enzyme-triggered fluorescent probe
Li, H., Yao, Q., Xu, F., Xu, N., Duan, R., Long, S., Fan, J., Du, J., Wang, J., & Peng, X. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.06.028 · Cited by 109
Gastric cancer‐derived exosomes promote peritoneal metastasis by destroying the mesothelial barrier
Deng, G., Qu, J., Zhang, Y., Che, X., Cheng, Y., Fan, Y., Zhang, S., Di, N., Liu, Y., & Qu, X. (2017) · FEBS Letters · doi:10.1002/1873-3468.12722 · Cited by 108
Self-citation
Recurrence-Associated Long Non-coding RNA Signature for Determining the Risk of Recurrence in Patients with Colon Cancer
Zhou, M., Hu, L., Zhang, Z., Wu, N., Sun, J., & Su, J. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.06.007 · Cited by 109
Feasibility of lung cancer screening in developing countries: challenges, opportunities and way forward
Shankar, A., Saini, D., Dubey, A., Roy, S., Bharati, S. J., Singh, N., Khanna, M., Prasad, C. P., Singh, M. K., Kumar, S., et al. (2019) · Translational Lung Cancer Research · doi:10.21037/tlcr.2019.03.03 · Cited by 112
Interference-free and high precision biosensor based on surface enhanced Raman spectroscopy integrated with surface molecularly imprinted polymer technology for tumor biomarker detection in human blood
Lin, X., Wang, Y., Wang, L., Lu, Y., Li, J., Lu, D., Zhou, T. J., Huang, Z., Huang, J. S., Huang, H., et al. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111599 · Cited by 109
Exosomal miRNA‐1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer
Shang, S., Wang, J., Chen, S., Tian, R., Zeng, H., Wang, L., Xia, M., Zhu, H., & Zuo, C. (2019) · Cancer Medicine · doi:10.1002/cam4.2633 · Cited by 109
Self-citation
FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer
Sun, C., Gao, W., Liu, J., Cheng, H., & Hao, J. (2020) · Respiratory Research · doi:10.1186/s12931-020-01477-y · Cited by 111
Human oral microbiome dysbiosis as a novel non-invasive biomarker in detection of colorectal cancer
Zhang, S., Kong, C., Yang, Y. P., Cai, S., Li, X., Cai, G., & Ma, Y. (2020) · Theranostics · doi:10.7150/thno.49515 · Cited by 113
Self-citation
Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer
Bai, Y., Xie, T., Wang, Z., Tong, S., Zhao, X., Zhao, F., Cai, J., Wei, X., Peng, Z., & Shen, L. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004080 · Cited by 109
Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)
Sun, J., Guo, R., Bi, X., Wu, M., Tang, Z., Lau, W. Y., Zheng, S., Wang, X., Yu, J., Chen, X., et al. (2022) · Liver Cancer · doi:10.1159/000523997 · Cited by 112
Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1α
Wan, W., Peng, K., Li, M., Qin, L., Tong, Z., Yan, J., Shen, B., & Yu, C. (2017) · Oncogene · doi:10.1038/onc.2017.13 · Cited by 108
FOXM1 promotes proliferation in human hepatocellular carcinoma cells by transcriptional activation of CCNB1
Chai, N., Xie, H., Yin, J., Sa, K.-D., Guo, Y., Wang, M., Liu, J., Zhang, X., Zhang, X., Yin, H., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.201 · Cited by 109
Comparison of the eighth version of the American Joint Committee on Cancer manual to the seventh version for colorectal cancer: A retrospective review of our data
Tong, G., Zhang, G., Liu, J., Zheng, Z., Chen, Y., Niu, P., & Xu, X. (2018) · World Journal of Clinical Oncology · doi:10.5306/wjco.v9.i7.148 · Cited by 108
LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer
Luo, K., Geng, J., Zhang, Q., Xu, Y., Zhou, X., Huang, Z., Shi, K., Pan, C., & Wu, J. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1263-3 · Cited by 108
Urinary microbiota – a potential biomarker and therapeutic target for bladder cancer
Bi, H., Tian, Y., Song, C., Li, J., Liu, T., Chen, Z., Chen, C., Huang, Y., & Zhang, Y. (2019) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001058 · Cited by 108
18F-FDG PET/CT radiomic predictors of pathologic complete response (pCR) to neoadjuvant chemotherapy in breast cancer patients
Li, P., Wang, X., Xu, C., Liu, C., Zheng, C., FULHAM, M. J., Feng, D. D., Wang, L., Song, S., & Huang, G. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04684-3 · Cited by 108
Gefitinib as neoadjuvant therapy for resectable stage II-IIIA non–small cell lung cancer: A phase II study
Zhang, Y., Fu, F., Hu, H., Wang, S., Li, Y., Hu, H., & Chen, H. (2020) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2020.02.131 · Cited by 108
ACE2 correlated with immune infiltration serves as a prognostic biomarker in endometrial carcinoma and renal papillary cell carcinoma: implication for COVID-19
Yang, H. J., Li, H., Hu, S., & Zhou, Y. (2020) · Aging · doi:10.18632/aging.103100 · Cited by 108
Progress in the application of sustained-release drug microspheres in tissue engineering
Ruan, L., Su, M., Qin, X., Ruan, Q., Lang, W., Wu, M., Chen, Y., & Lv, Q. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100394 · Cited by 108
Clinical significance of Fusobacterium nucleatum, epithelial–mesenchymal transition, and cancer stem cell markers in stage III/IV colorectal cancer patients
Yan, X., Liu, L., Li, H., Qin, H., & Sun, Z. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s145949 · Cited by 112
Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus
Wen, T., Chen, J., Facciorusso, A., Donadon, M., Han, H., Mao, Y., Dai, C., Cheng, S., Zhang, B., Peng, B., et al. (2018) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2018.08.01 · Cited by 110
Overexpressed circ_0067934 acts as an oncogene to facilitate cervical cancer progression via the miR‐545/EIF3C axis
Hu, C., Wang, Y., Li, A., Zhang, J., Xue, F., & Zhu, L. Y. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27601 · Cited by 107
PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells
Xu, S., Cui, F., Huang, D., Zhang, D., Zhu, A., Sun, X., Cao, Y., Ding, S., Wang, Y., Gao, E., et al. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s175340 · Cited by 106
Interactions among lncRNAs, miRNAs and mRNA in colorectal cancer
Tang, X. J., Wang, W. T., & Hann, S. S. (2019) · Biochimie · doi:10.1016/j.biochi.2019.05.010 · Cited by 107
Circular RNAs: pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer
Li, C., Zhang, L., Meng, G., Wang, Q., Lv, X., Zhang, J., & Li, J. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-03045-4 · Cited by 106
MRI-based radiomics of rectal cancer: preoperative assessment of the pathological features
Ma, X., Shen, F., Jia, Y., Xia, Y., Li, Q., & Lu, J. (2019) · BMC Medical Imaging · doi:10.1186/s12880-019-0392-7 · Cited by 107
LncRNA RUNX1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cells
Sun, L., Wang, L., Chen, T., Shi, Y., Yao, B., Liu, Z., Wang, Y., Li, Q., Liu, R., Niu, Y., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2274-x · Cited by 107
The role of PKM2 nuclear translocation in the constant activation of the NF-κB signaling pathway in cancer-associated fibroblasts
Gu, J., Li, X., Lin, Z., Yang, Y., Xue, C., Gao, Y., Li, J., Han, Q., Sun, Z., Bai, C., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03579-x · Cited by 107
Thermal‐Responsive MXene‐DNA Hydrogel for Near‐Infrared Light Triggered Localized Photothermal‐Chemo Synergistic Cancer Therapy
He, P., Du, X., Cheng, Y., Gao, Q., Liu, C., Wang, X., Wei, Y., Yu, Q., & Guo, W. (2022) · Small · doi:10.1002/smll.202200263 · Cited by 107
Antitumor Effects of Laminaria Extract Fucoxanthin on Lung Cancer
Mei, C., Zhou, S., Zhu, L., Ming, J., Zeng, F., & Xu, R. (2017) · Marine Drugs · doi:10.3390/md15020039 · Cited by 108
Preclinical studies for the combination of paclitaxel and curcumin in cancer therapy
Wei, Y., Pu, X., & Zhao, L. (2017) · Oncology Reports · doi:10.3892/or.2017.5593 · Cited by 106
lncRNA KCNQ1OT1 enhances the chemoresistance of oxaliplatin in colon cancer by targeting the miR-34a/ATG4B pathway
Li, Y., Li, C., Li, D., Yang, L., Jin, J., & Zhang, B. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s188054 · Cited by 106
The Jiangnan diet, a healthy diet pattern for Chinese
Wang, J., Lin, X., Bloomgarden, Z. T., & Ning, G. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.13015 · Cited by 108
IFI6 depletion inhibits esophageal squamous cell carcinoma progression through reactive oxygen species accumulation via mitochondrial dysfunction and endoplasmic reticulum stress
Liu, Z., Gu, S., Lu, T., Wu, K., Li, L., Dong, C., & Zhou, Y. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01646-3 · Cited by 108
Hypoxic tumour cell-derived exosomal miR-340-5p promotes radioresistance of oesophageal squamous cell carcinoma via KLF10
Chen, F., Xu, B., Li, J., Yang, X., Gu, J., Yao, X., & Sun, X. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01834-9 · Cited by 106
Integration of comprehensive genomic profiling, tumor mutational burden, and PD‐L1 expression to identify novel biomarkers of immunotherapy in non‐small cell lung cancer
Shi, Y., Lei, Y., Liu, L., Zhang, S., Wang, W., Zhao, J., Zhao, S., Dong, X., Yao, M., Wang, K., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.3649 · Cited by 110
Self-citation
Epidural Anesthesia–Analgesia and Recurrence-free Survival after Lung Cancer Surgery: A Randomized Trial
Xu, Z.-Z., Li, H.-J., Li, M.-H., Huang, S.-M., Li, X., Liu, Q.-H., Li, J., Li, X.-Y., Wang, D., & Sessler, D. I. (2021) · Anesthesiology · doi:10.1097/aln.0000000000003873 · Cited by 106
Discovery of Anticancer Agents of Diverse Natural Origin
Kinghorn, A. D., de Blanco, E. J. C., Lucas, D. M., RAKOTONDRAIBE, H. L., Orjala, J., Soejarto, D. D., Oberlies, N. H., Pearce, C. J., Wani, M. C., Stockwell, B. R., et al. (2016) · Anticancer Research · doi:10.21873/anticanres.11146 · Cited by 105
Clinical significance and diagnostic capacity of serum TK1, CEA, CA 19-9 and CA 72-4 levels in gastric and colorectal cancer patients
Ning, S., Wei, W., Li, J., Hou, B., Zhong, J., Xie, Y., Liu, H., Mo, X., Chen, J., & Zhang, L. (2018) · Journal of Cancer · doi:10.7150/jca.21562 · Cited by 105
TGF‐β‐mediated exosomal lnc‐MMP2‐2 regulates migration and invasion of lung cancer cells to the vasculature by promoting MMP2 expression
Wu, D., Deng, S., Liu, T., Han, R., Zhang, T., & Xu, Y. X. (2018) · Cancer Medicine · doi:10.1002/cam4.1758 · Cited by 105
Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers
Wang, Y., Lu, J., Wang, F., Wang, Y., He, M.-M., Wu, Q., Lu, Y., Yu, H., Chen, Z., Zhao, Q., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.12.036 · Cited by 106
CCT5 induces epithelial-mesenchymal transition to promote gastric cancer lymph node metastasis by activating the Wnt/β-catenin signalling pathway
Li, Y., Liu, C., Zhang, X., Huang, X., Liang, S., Xing, F., & Tian, H. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01747-0 · Cited by 105
Socioeconomic inequalities in cancer incidence and mortality: An analysis of GLOBOCAN 2022
Cao, W., Qin, K., Li, F., & Chen, W. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003140 · Cited by 105
“[29,30] Conversely, China demonstrated comparatively lower ASMRs for breast, prostate, and cervical cancers, likely influenced by genetic predisposition, and variations in cancer screening and detection practices.”
BackgroundSelf-citation
miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer
Chen, Y., Min, L., Ren, C., Xu, X., Yang, J., Sun, X., Wang, T., Wang, F., Sun, C., & Zhang, X. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171751 · Cited by 105
The emerging roles and therapeutic potential of exosomes in epithelial ovarian cancer
Li, X., & Wang, X. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0659-y · Cited by 106

Authors: Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J.
Affiliations: Deputy Director, National Office for Cancer Prevention and Control National Cancer Center Beijing China
Associate Researcher, National Office for Cancer Prevention and Control National Cancer Center Beijing China
Cancer Council Queensland (AU)
Associate Professor, National Office for Cancer Prevention and Control National Cancer Center Beijing China
Centre international de recherche sur le cancer (FR)
American Cancer Society (US)
The University of Sydney (AU)
Director National Cancer Center Beijing China.
Corresponding author: Chen, Wanqing
ORCID: Chen, Wanqing
Zheng, Rongshou
Baade, Peter D.
Zhang, Siwei
Zeng, Hongmei
Bray, Freddie
Jemal, Ahmedin
Yu, Xue Qin
He, Jie
Venue: CA: A Cancer Journal for Clinicians
Publisher: Wiley
Published: 2016-01-25
Volume: 66
Issue: 2
Pages: 115-132
ISSN: 0007-9235 (ISSN-L)
1542-4863
DOI: 10.3322/caac.21338
OpenAlex: W2272984102
Cited by: 17,038
References: 85
Citations by year: 2026: 142 · 2025: 461 · 2024: 1006 · 2023: 1271 · 2022: 1900 · 2021: 2470 · 2020: 2710 · 2019: 2630 · 2018: 2296 · 2017: 1648 · 2016: 486
FWCI: 1269.33
Type: journal article
Language: en
Open access: gold
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: CA A Cancer Journal for Clinicians (publishedVersion)
PubMed (publishedVersion)
Griffith Research Online (submittedVersion, other-oa)
The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
Funders: National Health and Family Planning Commission of China
Ministry of Science and Technology (2014FY121100)
Topics: Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
Keywords: cancer incidence, cancer mortality, cancer burden estimation, lung cancer, gastric cancer, esophageal cancer, liver cancer, urban-rural differences, cancer incidence trends, population-based cancer registry, cancer prevention, China
MeSH terms: Adult, Aged, China, Esophageal Neoplasms, Female, Humans, Liver Neoplasms, Lung Neoplasms, Male, Middle Aged, Neoplasms, Risk Factors, Rural Population, Stomach Neoplasms, Urban Population, Incidence, Prevalence, Survival Rate, Sex Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cancer statistics in China, 2015

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks